PDPs Applaud Japan’s First Public-Private Partnership to Spearhead Innovation in Global Health

A new public-private partnership of the Japanese Government, the Bill &Melinda Gates Foundation and a group of private pharmaceutical companies seeks to foster and harness Japanese innovation to address diseases that disproportionately affect low- and middle-income countries.
Earlier this week 13 pharmaceutical companies*, together with several government and nongovernmental organizations**, pledged to find solutions to eliminate or control 10 neglected tropical diseases (NTDs) by the year 2020. At an event in London, pharmaceutical companies committed to invest in research and development (R&D) to find new treatments for NTDs along with increasing donations of existing drugs.
This article, written by Dr. Peter Hotez, president of Sabin Vaccine Institute and dean of the National School of Tropical Medicine at Baylor College of Medicine, originally appeared in TAMEST (The Academy of Medicine, Engineering and Science of Texas) e-news.

Pages